Literature DB >> 746496

Reproducibility and comparison of responses to inhaled histamine and methacholine.

E F Juniper, P A Frith, C Dunnett, D W Cockcroft, F E Hargreave.   

Abstract

The efficiency of a standardised inhalation test procedure was studied by examining the reproducibility of responses to histamine and methacholine. In addition, the responses to the two agents were compared. Each set of duplicate tests was carried out on a separate day within one week, and all factors known or presumed to influence responses were carefully controlled. The results were expressed as the provocative concentration of the agent causing a 20% fall in forced expired volume in one second (PC20). Responses to histamine and methacholine were highly reproducible (coefficients of determination [r2] = 0.994 and 0.990 respectively). Responsiveness to histamine correlated closely with responsiveness to methacholine (r2 = 0.85). There was a small but significant cumulative dose effect with methacholine (P less than 0.01) but not with histamine. Side effects of throat irritation, flushing, and headache were more frequent with histamine than methacholine, and were dose-related. The high level of reproducibility indicates the efficiency of the test procedure. The similar severity of effects by agents with different mechanisms of action suggests that the primary cause of non-specific bronchial hyperreactivity lies at the level of bronchial smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 746496      PMCID: PMC470967          DOI: 10.1136/thx.33.6.705

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients.

Authors:  J T GOEI; H BOOY-NOORD; N G ORIE
Journal:  Int Arch Allergy Appl Immunol       Date:  1962

2.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

3.  Autonomic control of airway smooth muscle and airway secretions.

Authors:  J A Nadel
Journal:  Am Rev Respir Dis       Date:  1977-06

4.  Methacholine and physostigmine airway reactivity in asthmatic and nonasthmatic subjects.

Authors:  M M Miller; J E Fish; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1977-08       Impact factor: 10.793

5.  Effect of deep inspiration on airway conductance in subjects with allergic rhinitis and allergic asthma.

Authors:  J E Fish; V I Peterman; D W Cugell
Journal:  J Allergy Clin Immunol       Date:  1977-07       Impact factor: 10.793

6.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

7.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

8.  Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.

Authors:  D Pavia; M L Thomson; S W Clarke; H S Shannon
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

9.  Further studies on the mechanism of human histamine-induced asthma: the effect of an aerosolized H1 receptor antagonist (diphenhydramine).

Authors:  C L Casterline; R Evans
Journal:  J Allergy Clin Immunol       Date:  1977-06       Impact factor: 10.793

10.  The effect of atropine and albuterol aerosols on the human bronchial response to histamine.

Authors:  C L Casterline; R Evans; G W Ward
Journal:  J Allergy Clin Immunol       Date:  1976-11       Impact factor: 10.793

View more
  81 in total

Review 1.  Methodology of bronchial responsiveness.

Authors:  S Chinn
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Repeatability of methacholine challenge in asthmatic children measured by change in transcutaneous oxygen tension.

Authors:  S B Phagoo; N M Wilson; M Silverman
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

3.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

Review 4.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

5.  Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.

Authors:  Heather S Tomlinson; Sarah A Corlett; Martin B Allen; Henry Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

6.  Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects.

Authors:  S J Langley; S Goldthorpe; M Craven; A Woodcock; A Custovic
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

7.  Bronchoconstriction of the asthmatic airway by inhaled and ingested propranolol.

Authors:  K M Latimer; R E Ruffin
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Effect of antihistamines and antiallergic drugs on responses to allergen and histamine provocation tests in asthma.

Authors:  M J Phillips; S Ollier; C Gould; R J Davies
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

9.  Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease.

Authors:  A Avital; C Springer; E Bar-Yishay; S Godfrey
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

10.  Bronchial hyperresponsiveness following acute severe asthma.

Authors:  A Rabbat; J P Laaban; E Orvoën-Frija; M F Doré; A Achkar; J Rochemaure
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.